SEC Form 4Coverage since Jul 1, 2026
$LXEO insider trading
Over the last 12 months, Lexeo Therapeutics insiders reported no purchases and 4 sales totaling $257K across SEC Form 4 filings.
- Bought · 12m
- — 0 events
- Sold · 12m
- $257K 4 events
- Events · 12m
- 4 Form 4 filings, grouped
- Insiders · 12m
- 4 distinct reporters
- 10b5-1 share
- 0% pre-arranged plans
Side
Price · $LXEO · 12Mvia TradingView
Top insiders · 12m
Tamayo Louis EdwardChief Financial Officer1× · $21K
Otero Jose ManuelChief Operating Officer1× · $21K
Bhalla Narinder PalChief Medical Officer1× · $99K
Townsend Richard NolanChief Executive Officer1× · $116K
All insider trades
4 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jul 1, 2026 | Tamayo Louis EdwardChief Financial Officer · O | ▼ Sale | 4,641 | $4.49 | $21K | -4.6% | — |
| Jul 1, 2026 | Otero Jose ManuelChief Operating Officer · O | ▼ Sale | 4,666 | $4.48 | $21K | -3.3% | — |
| Jul 1, 2026 | Bhalla Narinder PalChief Medical Officer · O | ▼ Sale | 22,306 | $4.42 | $99K | -21.3% | — |
| Jul 1, 2026 | Townsend Richard NolanChief Executive Officer · O·D | ▼ Sale | 25,947 | $4.48 | $116K | -6.4% | — |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $LXEO feed.